Vibration Device Effect on Post-Injection Pain in The Upper Extremity
Launched by HATAN MORTADA · Dec 6, 2022
Trial Information
Current as of January 14, 2025
Unknown status
Keywords
ClinConnect Summary
Study design:
randomized controlled trial
Study duration:
12 months, beginning in November 2022 and ending in May 2023.
Study settings:
Data will be collected from patients coming to the plastic surgery department.
Study population: adult patients scheduled to receive local anesthesia or corticosteroid injections in their upper extremities.
Eligibility criteria: Adult patients with (ASA) physical status class 1 who are scheduled to receive local anesthesia or corticosteroid injections
Sample size:
60 adult patients who are attending plastic surgery clinic for upper extremity inject...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years of age
- • American Society of Anesthesiologists (ASA) physical status class I
- • Pain free
- • Adult patients scheduled to receive local anesthesia or corticosteroid injections in their upper extremities
- Exclusion Criteria:
- • Those on analgesic medications
- • Alcoholics, drug abusers
- • Pregnant patients
- • Menstruating women
- • Patients with reported allergies
- • Patients with acute infections
About Hatan Mortada
Hatan Mortada is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, Hatan Mortada collaborates with leading research institutions and healthcare professionals to ensure rigorous study design and ethical conduct in clinical trials. The organization prioritizes patient safety and data integrity, leveraging cutting-edge methodologies to facilitate the discovery of effective treatments across various therapeutic areas. Through its strategic partnerships and commitment to excellence, Hatan Mortada aims to contribute significantly to the enhancement of global health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Riyadh, Central Region, Saudi Arabia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials